ArticleFrontiers in molecular biosciences2022

Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2.

Kieun Bae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.